PercuSurge Committed To Boston Scientific Carotid Stent Trial

PercuSurge will proceed with plans to conduct U.S. trials of its GuardWire distal protection device with Boston Scientific's WallStent for carotid angioplasty, in spite of rival Medtronic's proposed purchase of the company for $225 mil., announced Oct. 19.